Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jokke Wynants"'
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 1140-1145 (2024)
Introduction: Treatment with topotecan is standard-of-care therapy for relapsed small-cell lung cancer (SCLC). Both oral and intravenous administrations of topotecan have been extensively researched and are found to be equally effective with less adv
Externí odkaz:
https://doaj.org/article/4c23d0a866b149489e2227808b19f841
Autor:
Aaron Caeyman, Olivia Vandekerckhove, Karin Pat, Jokke Wynants, Karolien Weytjens, Isabelle De Wergifosse, Kristof Cuppens
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 1095-1099 (2023)
In this report, we present a patient with metastatic non-small cell lung cancer who developed Sjögren’s syndrome secondary to immune checkpoint inhibition. This patient had a typical clinical presentation as well as biochemical signature, developi
Externí odkaz:
https://doaj.org/article/d9dc62c6c5e140ce9d3ec56fe72f26b0
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 2, Pp 625-630 (2019)
Epidermal growth factor receptor (EGFR)-targeted therapy has become standard of care in advanced stages EGFR-mutant non-small cell lung cancer. Acquired resistance to first-line EGFR-tyrosine kinase inhibitor (TKI) and subsequent disease progression
Externí odkaz:
https://doaj.org/article/feeb2b8f58d74f489cca4e3570319897
Autor:
Jan Verwerft, Lucie Soens, Jokke Wynants, Marc Meysman, Siddharth Jogani, Danielle Plein, Sarah Stroobants, Lieven Herbots, Frederik H Verbrugge
Publikováno v:
European Heart Journal. 44:1544-1556
Background and aims Heart failure with preserved ejection fraction (HFpEF) is a syndrome with a heterogeneous presentation. This study provides an in-;depth description of haemodynamic and metabolic alterations revealed by systematic assessment throu
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 12, Iss 2, Pp 625-630 (2019)
Case Reports in Oncology, Vol 12, Iss 2, Pp 625-630 (2019)
Epidermal growth factor receptor (EGFR)-targeted therapy has become standard of care in advanced stages EGFR-mutant non-small cell lung cancer. Acquired resistance to first-line EGFR-tyrosine kinase inhibitor (TKI) and subsequent disease progression
Autor:
Claus Vogelmeier, Rob Janssen, Christel Haenebalcke, Marko Topalovic, Nilakash Das, Emiel F.M. Wouters, Huib A. M. Kerstjens, Pierre-Régis Burgel, Christophe Pison, Renaud Louis, Marc Schlesser, Piet Vercauter, Giuseppe Liistro, Eric Derom, Wim Janssens, Vincent Ninane, Jokke Wynants, Marc Daenen
Publikováno v:
Clinical Problems.
Introduction: The use of pulmonary function tests (PFT) is built on an expert opinion. PFT interpretation relies on the recognition of patterns but scarcely leads to a specific respiratory disease diagnosis. We aimed to explore the accuracy and inter
Autor:
Deraedt, Davien1 (AUTHOR) davien.deraedt@uzleuven.be, Verfaillie, Saartje1,2 (AUTHOR), Wynants, Jokke1,2 (AUTHOR), Cuppens, Kristof1,2,3 (AUTHOR)
Publikováno v:
Case Reports in Oncology. Oct2024, Vol. 17 Issue 1, p1140-1145. 6p. 2 Illustrations.
Publikováno v:
Radiologic clinics of North America. 45(4)
Imaging techniques play a vital role in the diagnosis, staging, and follow-up of patients who have lung cancer. For this purpose, PET has become an important adjunct to conventional imaging techniques such as chest radiography, CT, ultrasonography, a
Autor:
Caeyman, Aaron1 (AUTHOR), Vandekerckhove, Olivia2 (AUTHOR), Pat, Karin3 (AUTHOR), Wynants, Jokke3 (AUTHOR), Weytjens, Karolien3 (AUTHOR), De Wergifosse, Isabelle4 (AUTHOR), Cuppens, Kristof3 (AUTHOR)
Publikováno v:
Case Reports in Oncology. 2023, Vol. 16 Issue 1, p1095-1099. 5p.